Particle.news
Download on the App Store

Enlivex Raises $212 Million to Shift Treasury Into RAIN Prediction-Market Token

The Nasdaq-listed biotech is pursuing a dual track that couples Allocetra development with a plan to make RAIN its primary reserve asset after the private placement closes.

Overview

  • Enlivex entered a PIPE to sell 212,000,000 shares at $1.00 each for expected gross proceeds of about $212 million, with settlement in U.S. dollars and USDT.
  • The company says it will accumulate RAIN tokens and designate RAIN as its main treasury reserve, positioning it as the first U.S.-traded public company to offer investors exposure to prediction markets.
  • Closing is expected on or before Nov. 25, 2025, subject to customary conditions, with BTIG serving as the sole placement agent.
  • RAIN, an Arbitrum-based predictions and options protocol with AI-assisted resolution and a buyback-and-burn mechanism, saw its token price jump roughly 100% after the news.
  • Former Italian Prime Minister Matteo Renzi is slated to join the board following the closing, and Enlivex reported positive six-month Phase 2a Allocetra efficacy data in knee osteoarthritis.